Introduction Poly-γ-glutamic acid (γ-PGA) with different molecular weight (Mw) exhibits different properties and therefore has a variety of applications. At present, the γ-PGA is mainly produced by Bacillus species. However, the production of γ-PGAs with specific Mws often requires multiple strains, which limits the development and application of γ-PGA. Methods To address this limitation, we constructed an engineered Bacillus subtilis strain by deleting hydrolase genes cwlO , pgdS and ggt , and further introduced regulation of PgdS expression under an IPTG-inducible promoter. Results When the hydrolase genes cwlO , pgdS and ggt in B. subtilis were deleted, the γ-PGA Mw and titer increased by 220.1% (2.42×10 7 Da) and 47.81% (8.44 g/L), respectively. Furthermore, regulation of PgdS expression enabled dynamic control of γ-PGA Mw. The γ-PGA with Mw ranging from 9.55×10 4 Da to 2.15×10 7 Da was produced by change of IPTG addition time in an engineered strain, with the titer of 6.28-8.57 g/L. In the 5-L fermenter, the γ-PGA with Mw ranging from 8.3×10 4 Da to 1.87×10 7 Da was produced under optimal conditions. Conclusion In summary, an engineered strain that can dynamically regulate the γ-PGA Mw and produce γ-PGAs with specific Mws was obtained, and its regulatory range was wider than that of previous studies, which increased the application potential.
Yu et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: